Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

Abstract

A first-in-human evaluation of baroreflex activation therapy for resustant hypertension has been completed. The Rheos system provided clinically meaningful and sustained reductions in BP in high-risk patients.

The device implant and therapy demonstrated favorable safety, and each was well torelated.

Keywords

• resistant hypertension
• baroreflex activation therapy
• electrical stimulation